Buchumschlag

Targeting ion channels in cystic fibrosis

Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause a characteristic defect in epithelial ion transport that plays a central role in the pathogenesis of cystic fibrosis (CF). Hence, pharmacological correction of this ion transport defect by targeting of mutant CFTR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mall, Marcus A. (VerfasserIn) , Galietta, Luis J.V. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 June 2015
In: Journal of cystic fibrosis
Year: 2015, Jahrgang: 14, Heft: 5, Pages: 561-570
ISSN:1873-5010
DOI:10.1016/j.jcf.2015.06.002
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jcf.2015.06.002
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S1569199315001502
Volltext
Verfasserangaben:Marcus A. Mall, Luis J.V. Galietta

MARC

LEADER 00000caa a2200000 c 4500
001 1699967008
003 DE-627
005 20220818113324.0
007 cr uuu---uuuuu
008 200605s2015 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jcf.2015.06.002  |2 doi 
035 |a (DE-627)1699967008 
035 |a (DE-599)KXP1699967008 
035 |a (OCoLC)1341328415 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mall, Marcus A.  |d 1975-  |e VerfasserIn  |0 (DE-588)115507795  |0 (DE-627)691370532  |0 (DE-576)28992152X  |4 aut 
245 1 0 |a Targeting ion channels in cystic fibrosis  |c Marcus A. Mall, Luis J.V. Galietta 
264 1 |c 23 June 2015 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.06.2020 
520 |a Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause a characteristic defect in epithelial ion transport that plays a central role in the pathogenesis of cystic fibrosis (CF). Hence, pharmacological correction of this ion transport defect by targeting of mutant CFTR, or alternative ion channels that may compensate for CFTR dysfunction, has long been considered as an attractive approach to a causal therapy of this life-limiting disease. The recent introduction of the CFTR potentiator ivacaftor into the therapy of a subgroup of patients with specific CFTR mutations was a major milestone and enormous stimulus for seeking effective ion transport modulators for all patients with CF. In this review, we discuss recent breakthroughs and setbacks with CFTR modulators designed to rescue mutant CFTR including the common mutation F508del. Further, we examine the alternative chloride channels TMEM16A and SLC26A9, as well as the epithelial sodium channel ENaC as alternative targets in CF lung disease, which remains the major cause of morbidity and mortality in patients with CF. Finally, we will focus on the hurdles that still need to be overcome to make effective ion transport modulation therapies available for all patients with CF irrespective of their CFTR genotype. 
650 4 |a Alternative chloride channels 
650 4 |a CFTR modulators 
650 4 |a ENaC 
650 4 |a Pharmacotherapy 
650 4 |a SLC26A9 
650 4 |a TMEM16A 
700 1 |a Galietta, Luis J.V.  |e VerfasserIn  |0 (DE-588)1211561054  |0 (DE-627)1699967997  |4 aut 
773 0 8 |i Enthalten in  |t Journal of cystic fibrosis  |d Amsterdam [u.a.] : Elsevier Science, 2002  |g 14(2015), 5, Seite 561-570  |h Online-Ressource  |w (DE-627)35598539X  |w (DE-600)2091075-7  |w (DE-576)271360909  |x 1873-5010  |7 nnas  |a Targeting ion channels in cystic fibrosis 
773 1 8 |g volume:14  |g year:2015  |g number:5  |g pages:561-570  |g extent:10  |a Targeting ion channels in cystic fibrosis 
856 4 0 |u https://doi.org/10.1016/j.jcf.2015.06.002  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1569199315001502  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200605 
993 |a Article 
994 |a 2015 
998 |g 115507795  |a Mall, Marcus A.  |m 115507795:Mall, Marcus A.  |d 910000  |d 910500  |e 910000PM115507795  |e 910500PM115507795  |k 0/910000/  |k 1/910000/910500/  |p 1  |x j 
999 |a KXP-PPN1699967008  |e 3683468459 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Targeting ion channels in cystic fibrosis","title":"Targeting ion channels in cystic fibrosis"}],"person":[{"roleDisplay":"VerfasserIn","display":"Mall, Marcus A.","role":"aut","family":"Mall","given":"Marcus A."},{"role":"aut","display":"Galietta, Luis J.V.","roleDisplay":"VerfasserIn","given":"Luis J.V.","family":"Galietta"}],"language":["eng"],"recId":"1699967008","note":["Gesehen am 05.06.2020"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1016/j.jcf.2015.06.002"],"eki":["1699967008"]},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"23 June 2015"}],"name":{"displayForm":["Marcus A. Mall, Luis J.V. Galietta"]},"relHost":[{"note":["Gesehen am 10.02.2016"],"disp":"Targeting ion channels in cystic fibrosisJournal of cystic fibrosis","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"35598539X","pubHistory":["1.2002 -"],"titleAlt":[{"title":"Cystic fibrosis"}],"part":{"extent":"10","volume":"14","text":"14(2015), 5, Seite 561-570","issue":"5","pages":"561-570","year":"2015"},"title":[{"title_sort":"Journal of cystic fibrosis","subtitle":"the official journal of the European Cystic Fibrosis Society","title":"Journal of cystic fibrosis"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"2002-","dateIssuedKey":"2002","publisher":"Elsevier Science"}],"id":{"issn":["1873-5010"],"zdb":["2091075-7"],"eki":["35598539X"]}}],"physDesc":[{"extent":"10 S."}]} 
SRT |a MALLMARCUSTARGETINGI2320 

Ähnliche Einträge